ELMIRON caps 100 mg bte 90 pce

7680673060018 CH-67306 G04BX15 05.02.0.

Reimbursement limitations:

ELMIRON

Après accord préalable de prise en charge des coûts par l’assureur-maladie, pour le traitement symptomatique …

ELMIRON caps 100 mg bte 90 pce
ELMIRON caps 100 mg bte 90 pce
ELMIRON caps 100 mg bte 90 pce
1 / 3
google

Details

Product number
6730601
CPT
-
Packaging group
90
Unit
Kapsel(n)
Composition
heparinoidum (natrii pentosani polysulfas) 100 mg, excipiens pro capsula.

Articles (1)

Elmiron 100 mg, Kapseln
Kapseln
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/01/2022
Patient information leaflet
Français
13/01/2022
Patient information leaflet
Italien
13/01/2022
Professional SmPC
Allemand
13/01/2022
Professional SmPC
Français
13/01/2022
Professional SmPC
Italien
13/01/2022

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)

Reimbursement information

Public price
CHF 517.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2022

Authorization holder

Curatis AG

4410 Liestal

Authorization information

Swissmedic authorization number
67306
Drug name
Elmiron, Kapseln
Galenic form
KAPS
ATC Code
G04BX15
Authorization status
Z
Dispensation category
B
First authorization
24/09/2020
Authorization expiration date
31/12/9999
IT number
05.02.0.
Domain
Human medicine
Field of application
Chronische Blasenschmerzen bei Erwachsenen sowie Harndrang und Miktionshäufigkeit

Packaging details

Description (FR)
ELMIRON caps 100 mg bte 90 pce
Description (DE)
ELMIRON Kaps 100 mg Ds 90 Stk
Market launch
24/09/2020
Narcotic (BTM)
No

Other packaging sizes